Back

Horizon Europe Project LiverTarget gets funded

Horizon Europe Project LiverTarget gets funded

LiverTarget is an international consortium that aims to deliver RNA therapeutics to the liver. The liver plays a central role in several cardiovascular disorders because of its key function in metabolic processes like lipid distribution. Using RNA therapeutics, metabolic pathways can be activated or downregulated to delineate their role in cardiovascular disease. The total grant is worth 6 million euro. For more information: Prof. dr. Raymond Schiffelers, professor of nanomedicine, r.schiffelers@umcutrecht.nl

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not